Bowel Dysfunction

Liraglutide reduced stool frequency in a small subset of patients with bile acid diarrhea and warrants consideration as a potential new treatment modality, according to research in The Lancet Gastroenterology and Hepatology.

Upadacitinib induced sustained improvements in abdominal pain, bowel urgency and fatigue in patients with moderate to severe ulcerative colitis, according to research presented at ECCO.

For the first time, researchers characterized normal bowel habits for adults in the United States.